Abstract. Tumor immunity to a transplantable diethylnitrosamine-iniduced hepatoma in inbred guinea pigs has been found to be immunologically specific and cell mediated. We have investigated this cellular immunity using a quantitative, reproducible, and simple assay based on the ability of leucocytes to inhibit the incorporation of tritiated thymidine (TdR3H) by tumor cells. Tumor cell suspensions were obtained from the ascites form or tissue culture monolayers of the hepatoma. Cells from the peritoneal exudate of immunized guinea pigs inhibited tritiated thymidine uptake by tumor target cells to a significantly greater degree than cells from the peritoneal exudate of unimmunized animals. Immune lymph node, peripheral blood, and spleen leucocytes were not inhibitory. The assay was sufficiently sensitive to detect relatively weak tumor immunity. The in vitro inhibition was correlated directly with the presence of delayed hypersensitivity and/or inhibition of tumor cell growth in local passive transfer studies. Irradiation of peritoneal exudate cells (3000 R) blocked their inhibitory effects on tumor cells. Fractionation of the peritoneal exudate cells by ceiitrifugation in zones of bovine serum albumin of different density also revealed the lymphocytes to be responsible for the specific inhibitory effects whereas macrophages inhibited in an immunologically nonspecific fashion. 
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The existence of specific cellular immunity in inbred guinea pigs against transplantable hepatomas induced by diethylnitrosamine has been demonstrated.' Such guinea pigs, when immunized with tumor cells designated as line 1, develop typical delayed hypersensitivity reactions to line 1 cells and suppress line 1 tumor growth at the site of intracutaneous tumor cell injection. A variety of assays have failed to detect humoral antitumor immunity in these guinea pigs. 6 .0 Ci/mM, Schwarz BioResearch). They were processed for radioactivity precipitable by trichloroacetic acid as previously described. 9 Statistical analysis: The data was transformed to logarithmic numbers because the degree of variation was observed to be proportional to the value of the counts per minute (cpm). A polynomial regression analysis was done on the logarithmically transformed data using a computer program (prepared by Dr. C. MacLean). This revealed that the standard error of the estimate of cpm ranged from 9 to 34.6% with a mean of 15%. Hence any two points that differ by more than 30% usually exceed the At the optimal concentration of 5 X 105, the sensitized PE cells inhibited uptake of TdR3H maximally in cultures containing from 103 to 105 line 1 tumor cells. The inhibition of tumor cell growth was not significant when 106 line 1 tumor cells were present. Therefore, the most complete inhibition was obtained at ratios of sensitized PE cells to tumor cells of 50: 1, but the number of counts decreased maximally at 10:1. However, significant inhibition was evident even at ratios of 1: 1.
In a number of experiments, suspensions of 104-106 line 1 tumor cells were prepared from tissue culture monolayers. The ability of sensitized PE cells to inhibit the TdR3H uptake by these tumor cells was comparable to their inhibition of ascites tumor cells.
Kinetics of in vitro tumor cell inhibition: Significant inhibition of tumor cell incorporation of TdR3H by sensitized PE cells was apparent after only 19 hr of incubation. The degree of inhibition was greater after 44 and 66 hr of incubation. This increased inhibition of tumor cell DNA synthesis by the sensitized, and to a lesser degree control, PE cells indicated that inhibition occurred throughout the incubation period. This increment in specific inhibition with time occurs despite a concommitant progressively increased tumor cell growth over the same period of time. However, by the seventh day of incubation, the tumor cell growth had exceeded the inhibitory effects of control as well as sensitized PE cells, except at the lower initial tumor cell concentration of 103-104 ml.
The rapidity with which PE cells cause demonstrable tumor inhibition in vitro suggests that DNA synthesis by lymphocytes contributes little to the TdR3H incorporation by the cultures. In these experiments phytohemaglutinin-stimulated PE cell cultures did not incorporate TdJPH until 66 hr of incubation, whereas PE cells already inhibited tumor cells by 19 and 44 hr. Therefore, it is unlikely that the tumor cell antigens would have stimulated significant lymphocyte proliferation until 66 hr of incubation. Furthermore, our attempts to demonstrate PE lymphocyte proliferation when mixed with irradiated (15,000 R, 200 kV, 15 mA. Westinghouse Quadrocondex x-ray machine) tumor cells and incubated for 3-7 days were unsuccessful. Irradiation blocked 95%0 or more of the tumor cell TdR3H uptake but failed to reveal any significant increment in DNA synthesis in cultures containing both tumor and sensitized or control PE cells. Therefore, incorporation of TdR3H by lymphocytes presumably did not interfere with our detection of inhibition of tumor cell growth.
Localization of sensitized cells in vivo: We compared the efficacy of leucocytes obtained from the peritoneal exudate with those from axillary, inguinal and mesenteric lymph nodes, peripheral blood, and spleens of immunized and control guinea pigs in inhibiting tumor cell DNA synthesis. Only the sensitized PE cells were able to inhibit line 1 cell growth to a greater degree than control cells. There was no detectable specific inhibition by lymph node and spleen cells even when concentrations as high as 1 and 2 X 106/ml were used. Specific lymph node, peripheral blood, and spleen leucocytes incubated on a shaker (4-6/min) also failed to show any specific inhibitory effects. Furthermore, attempts to elicit specific inhibition by 5 X 105/ml sensitized spleen and lymph node cells by mixing them with 5 X 104/ml autologous PE cells were not successful. Thus inadequate "processing" of tumor antigens by macrophages is not likely to be responsible for the failure of lymph node and spleen cells from immunized animals to inhibit tumor cell DNA synthesis. In contrast, in 16 of 18 experiments, the sensitized PE cells were more inhibitory thAn control PE cells. One of the negative experiments was contaminated with bacteria and in the other the local passive transfer test was also negative. We therefore conclude that the distribution of sensitized cells capable of inhibiting tumor cell growth is uneven and greatest in the PE cell population.
Effect of various types of peritoneal exudate cells: PE cells were fractionated by centrifugation in tubes containing zones of albumin of different density (Fig. 2) little specific of TdR3H incorporation by the tumor cells. The middle fraction (II) manifested the same degree of nonspecific but less specific inhibition than the unfractionated PE cells. It was in the lymphocyte and neutrophil-rich fraction (III) that the degree of specific inhibition by the sensitized cells was enriched, whereas the degree of nonspecific inhibition was diminished in comparison with the unfractionated PE. These results suggest that the mechanism of inhibition by macrophages is immunologically nonspecific, whereas the PE lymphocytes are responsible for the specific inhibition of tumor cell TdR3H incorporation. Effect of irradiation of peritoneal exudate cells: Irradiation (3000 R) of PE cells increased the degree of nonspecific tumor cell inhibition and ablated the specific tumor cell inhibition of sensitized PE cells ( PE cell suppression of tumor cell growth involves a radiosensitive process. This result also supports the aforementioned observation that lymphocytes rather than macrophages are responsible for the immunologically specific inhibition, since lymphocytes are considerably more radiosensitive than the macrophages.10 Specificity of in vitro inhibition: We compared the inhibitory effect of PE cells sensitized to line 1 or to line 7 on the DNA synthesis of line 1 tumor cells. At a concentration of 5 X 105 PE cells/ml, the anti-1 PE cells inhibited from 103 to 5 X 105 line 1 cell growth to a greater degree than anti-7 PE cells. The latter therefore behaved like the control PE cells in the previous experiments.
Inhibition of line 7 by peritoneal exucate cells: The sensitivity of the assay was tested by comparing the inhibitory effect on line 7 ascites tumor cells of control versus anti-7 PE cells. This tumor line usually does not evoke delayed cutaneous hypersensitivity reactions. We were able to demonstrate specific inhibition of line 7 tumor cells in vitro by using PE cells from guinea pigs which had received six intracutaneous injections of line 7 tumor cells. Since the presence of delayed hypersensitivity has been correlated with tumor immunity, detection of inhibition of tumor DNA synthesis in its absence indicates that our assay was more sensitive in detecting such cellular immunity than the skin tests.
Discussion. We have presented additional experimental evidence for the existence of cell-mediated tumor immunity in inbred guinea pigs against several diethylnitrosamine-induced tumors. This has been achieved using a relatively simple, quantitative, reproducible, and rapid assay of inhibition of TdR3H incorporation by ascites and tissue culture suspensions of tumor cells. Such inhibition was detectable after only 19 hr of incubating mixtures of guinea pig peritoneal exudate cells and tumor cells. This phenomenon was immunologically specific since PE cells from guinea pigs immunized with a particular tumor line consistently produced greater inhibition of that tumor's cell growth than normal PE cells or exudate cells immunized with an antigenically unrelated tumor. In contrast with other studies,3 we used syngeneic animals to ensure that tumor rather than histocompatibility antigens were responsible for this effect. The assay detects such specific inhibition over a wide range of tumor cell concentrations. Occasionally total inhibition was seen at lower concentrations of less than 104 tumor cells/ml and it became less evident or totally obscured in the presence of more than 106 tumor cells/ml. The specific inhibitory effects could be detected over a wide range of PE to tumor cell ratios of 50:1-1:1. When more than 106 PE cells were used, increased nonspecific inhibition usually resulted in obscuring any immunologically specific effects.
This specific inhibition of tumor cell growth in vitro by sensitized PE cells was directly correlated with positive local passive transfer of delayed cutaneous reactivity. This reactivity in turn has been associated with suppression of in vivo tumor cell growth. 7 The in vitro assay was also sufficiently sensitive to detect inhibition of tumor cell growth even in the case of the less-antigen line 7 tumor. Line 7 is inhibited in in vivo passive transfer studies by sensitized PE cells with little or no evidence of associated delayed inflammatory reaction.
However, the in vitro assay failed to detect any immunologically specific inhibition by peripheral blood leucocyte, lymph node, or spleen cell suspensions from guinea pigs with effective sensitized PE cells. Sensitized lymph node and spleen cells have also failed to inhibit tumor growth in passive and systemic transfer experiments. '1 Studies with fractionated PE cells showed that cell fractions rich in lymphocytes and neutrophils were responsible for specific inhibitory effects; inhibition caused by macrophage rich fractions was nonspecific. This lymphocyte-rich fraction also exhibited the greatest activity in local and systemic passive transfer experiments.8 Irradiation of the PE cells blocked the specific immune inhibitory effects which also suggests that the lymphocyte is responsible for the specific response. Irradiated PE cells also failed to suppress tumor growth in the local passive transfer assay.2 Thus, PE cells contain either more potent or greater proportions of lymphocytes specifically able to inhibit tumor cell growth than lymphocytes from other sources. Investigations by Pick et al.12 and Old'3 have shown greater efficacy of PE cells in several assays of cellular immunity. This supports the view that these exudates contain very potent lymphocytic mediators of cellular immunity.
The mechanism by which PE lymphocytes inhibit tumor cell growth is not clear. There is no evidence of participation of antibodies in the immune response of the guinea pigs to the tumors. The process appears to be radiosensitive but also is apparent before any measurable degree of antigenically stimulated in vitro lymphocyte DNA synthesis. The inhibition may in part be reversible but at times is probably caused by irreversible cytotoxic effects since occasionally tumor cell growth was completely inhibited. Whether the inhibition of tumor cell growth requires cell-cell contact14 or may be mediated by lymphotoxin15 16 or a proliferation inhibition factor' remains to be seen.
This in vitro assay can and should be applied to the study of human tumor immunity. It would be especially appropriate when identical twins or HI-A matched subjects with and without tumors are available. Our findings suggest that testing the influence of lymphocytes on DNA synthesis by tumor cells could be used to monitor varying degrees of tumor immunity in man.
